US research funding at KI
Karolinska Institutet is the largest recipient of external research funding from the United States among Swedish universities. In 2021, US financiers contributed just over SEK 101 million to KI's research, with grants from both federal funders such as the National Institutes of Health (NIH) and private foundations.
US federal PI-initiated research grants
CDC (Centers for Disease Control and Prevention) - 2021
Fang Fang (R01/Prime) - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden
NIH – 2023
- Anna Norrby-Teglund (R01/Sub) Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus
NIH - 2022
- Malin Ernberg (UC2/Sub) Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD)
- Josefin Särnholm (P30/Sub) Columbia Roybal Center for fearless behavior change
- Rickard Sandberg (U01/Sub) Comprehensive single-cell atlas of the developing mouse brain
- Sten Linnarsson and Rickard Sandberg (UM1/Sub) Functionally guided adult whole brain cell atlas in human and NHP
NIH – 2021
- Elisabet Svenungsson (R01/Sub) -Role of mitochondria in SLE and its cardiovascular complications
- Carina King (R21/Sub) - Development and implementation of pediatric mobile phone reflectance pulse oximeters and a hypoxemia surveillance system in South Africa
- Jan Albert (R01/Sub) - Next-generation algorithms using multiple biomarkers for precise estimation of HIV infection duration and population level incidence
- Rikard Holmdahl (R15/Sub) - Autoantibody modulation of cartilage turnover in rheumatoid arthritis
- Benjamin Murrell (R01/Sub) - HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy
- Sara Hagg (R01/Prime) - Repurposing drugs for Alzheimer´s disease using a reverse translational approach
- Alek Erickson (F32/Prime) - Signaling mechanisms underlying neural crest cell fate decisions
- Mikael Karlsson (R01/Sub) - Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
- Ulrika Marklund (R01/Sub) - Neurobiology of Intrinsic Primary Afferent Neurons
- Petter Brodin (U01/Sub) - Enhancing immunity to malaria in young children with effective chemoprevention
- Ingrid Lundberg (R21/Sub) - Extracellular mitochondria in Inclusion Body Myositis
- Gunilla Karlsson Hedestam (P01) – HIV vaccine research and design
NIH – 2020
- Lars Terenius (R01/Prime) – Drug targeting the dynamics of opioid systems in alcohol dependence
- Anna Marseglia (R24/Sub) – Developing a biological marker of cognitive reserve with deep learning from multimodal structural MRI
- Nina Bohm-Starke (R21/Sub) – Risk of vulvodynia due to immune-related health events throughout the life course
- Yi Lu (R01/Sub) – A Trans-Nordic Study of Extreme Major Depression
- Sarah Bergen (R01/Prime) – A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study
- Ivan Nalvarte (R01/Prime) – Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk
- Elizabeth Arkema (R01/Sub) – Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
NIH – 2019
- Sara Öberg (R01/Sub) – Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes
- Gunilla Karlsson Hedestam (P51/Sub) – Support of Yerkes National Primate Research Center
Karl Eriksson (U01/Sub) – STABILITY 2: ACL Reconstruction +/- Lateral Tenodesis with Patellar vs. Quad Tendon
- Sven Cnattingius (R21/Sub) – Prenatal and Neonatal Risk Factors for Adverse Neurodevelopmental Outcomes in Childhood and Early Adulthood
- Gunilla Karlsson Hedestam (UM1/Sub) – Consortium for HIV/AIDS Vaccine Development
- Cecilia Magnusson (R01/Sub) – Maternal epilepsy, antiepileptic drug use during pregnancy, and risk of autism
- Benjamin Murrell (UM1/Sub) – HVTN Laboratory Center
NIH – 2018
- Sarah Bergen (R21/Prime) – Schizophrenia Comorbidities: Common Genes and Clusters
NIH – 2017
- Tatiana Deliagina (R01/Sub) - Neural Mechanisms of Locomotion Evoked by Epidural Stimulation of the Spinal Cord
- Sara Öberg (R01/Sub) - Long-term Impact of Fertility Treatment Study
- Johan Grunewald (R01/Sub) – T cell epitopes in sarcoidosis
- Rickard Sandberg (R01/Sub) – Deciphering the building blocks of hippocampal circuits
- Maria Sabater Lleal (R01/Sub) – Population genomic variation, functional biology, and the risk of venous thrombosis
- Rickard Sandberg (U19/Sub) – A comprehensive whole-brain atlas of cell types in the mouse
- Sten Linnarsson (U01/Sub) – A multimodal atlas of human brain cell types
- Barbara Canlon (R56/Prime) – Circadian regulation of glucocorticoid-dependent inflammation in noise-induced synaptopathy
- Michael Yi Bonner (F31/Prime) – Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy
- Ivanka Savic-Berglund (R01/Sub) – Gender identity and own body perception implications for the neurobiology of gender dysphoria
- Gunilla Karlsson Hedestam (U01/Sub) – Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection
NIH – 2016
- Ahmed Elewa (F32/Prime) – Discovering signature genes and developing expression markers for blastema cells
- David Mataix-Cols (R01/Sub) – OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms.
- Elias Arnér (R21/Sub) - Redox regulation in the hepatostat.
- Fredrik Wiklund (R01/Sub) – The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation.
- Konstantinos Meletis (R21/Sub) – Development of a whole-brain cellular mapping approach in a genetic model of autism and intellectual disability.
- Nancy Pedersen (R56/Sub) – Gene-Environment Interplay of Social contexts and Aging-Related Outcomes.
- Ujjwal Neogi (R01/Sub) – Reverse Transcriptase Multi-Class Drug Resistance and Rilpivirine Susceptibility in Diverse HIV-1 Subtypes.
Department of Defense (DoD)
2021: Camilla Svensson (CDMRP/Sub) - Fc gamma receptor signaling: a new pathway for sustained neuropathic pain
2020: Samir EL Andaloussi (CDMRP/Prime) - Muscle-Targeted Cell-Penetrating Peptides for Delivery of Cas9-RNPs and Modified mRNA to Dystrophic Muscle
2017: Helena Ledmyr (Office of Naval Research) – CSP – The 10th Neuroinformatics Congress of the International Neuroinformatics Coordinating Facility (INCF)
2016: Barbara Canlon (CDMRP/Prime) – Chronopharmacological Interventions for the Successful Treatment of Noise-Induced Hearing Loss
2015: Theresa Vincent (CDMRP/Sub) – Targeting Breast Cancer Metastasis through Selective Inhibition of RNA Polymerase I
Major private foundation PI-initiated research grants
Bill & Melinda Gates Foundation:
- Karin Loré (Prime) - COVID-19: NHP Study of Novavax nanoparticle at Karolinska
- Anna Smed Sörensen – (Prime) - COVID-19: blood and airway disease in Sweden
- Karin Loré (Prime) - Immunogenicity study of CureVac’s mRNA vaccine for Covid-19 in rhesus macaques
- Helena Lindgren – Maternal and child health-care in Sub-Saharan African countries.
Bill & Melinda Gates Foundation:
Karin Loré (Prime) – Analyse the immune responses elicited by novel mRNA-based vaccines.
Bill & Melinda Gates Foundation: Karin Loré (Sub) – Structure Based Immunogen Design at UWIPD.
Jeffrey Modell Foundation: Lennart Hammarström (Sub)
Patient-Centered Outcomes Research Institute (PCORI): Fredrik Piehl (Prime) – Rituximab in Multiple Sclerosis: A Comparative Study on Effectiveness, Safety, and Patient-Reported Outcomes. Read a news article on KI News
Bill & Melinda Gates Foundation:
CHDI Foundation Inc: Christer Halldin
The Myositis Association: Ingrid Lundberg
The Vallee Foundation: Rickard Sandberg (Vallee Scholar) – The nature of allelic gene expression in vivo.